NDLI: Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.

Please wait, while we are loading the content...

Year: 2016, Volume: 60

Year: 2015, Volume: 60

Year: 2015, Volume: 59

Year: 2014, Volume: 59

Year: 2014, Volume: 58

Year: 2013, Volume: 57

Year: 2012, Volume: 56

Year: 2011, Volume: 55

Year: 2010, Volume: 54

Year: 2009, Volume: 53

Year: 2008, Volume: 52

Year: 2007, Volume: 51

Year: 2006, Volume: 50

Year: 2005, Volume: 49

Year: 2004, Volume: 48

Year: 2003, Volume: 47

Year: 2002, Volume: 46

Year: 2001, Volume: 45

Year: 2000, Volume: 44

Year: 1999, Volume: 43

Year: 1998, Volume: 42

Year: 1997, Volume: 41

Year: 1996, Volume: 40

Year: 1995, Volume: 39

Year: 1994, Volume: 38

Year: 1994, Volume: 38, Issue: 12

How the pharmaceutical industry brings an antibiotic drug to market in the United States.

Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.

Evidence of alkaline phosphatase interference in a zidovudine radioimmunoassay.

Pharmacokinetics, toxicity, and efficacy of liposomal capreomycin in disseminated Mycobacterium avium beige mouse model.

Pharmacodynamics of levofloxacin, ofloxacin, and ciprofloxacin, alone and in combination with rifampin, against methicillin-susceptible and -resistant Staphylococcus aureus in an in vitro infection model.

The N-7-substituted acyclic nucleoside analog 2-amino-7-[(1,3-dihydroxy-2-propoxy)methyl]purine is a potent and selective inhibitor of herpesvirus replication.

Clarithromycin, dapsone, and a combination of both used to treat or prevent disseminated Mycobacterium avium infection in beige mice.

Pharmacokinetics, oral bioavailability, and metabolism in mice and cynomolgus monkeys of (2'R,5'S-)-cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl] cytosine, an agent active against human immunodeficiency virus and human hepatitis B virus.

Pharmacokinetic and pharmacodynamic activities of ciprofloxacin against strains of Streptococcus pneumoniae, Staphylococcus aureus, and Pseudomonas aeruginosa for which MICs are similar.

Effects of clarithromycin and rifabutin alone and in combination on intracellular and extracellular replication of Mycobacterium avium.

Effects of antiviral nucleoside analogs on human DNA polymerases and mitochondrial DNA synthesis.

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.

Pharmacokinetics of the triazole antifungal agent genaconazole in healthy men after oral and intravenous administration.

Application of a radioimmunoassay for determination of levels of zalcitabine (ddC) in human plasma, urine, and cerebrospinal fluid.

Quantification, qualification, and microbial killing efficiencies of antimicrobial chlorine-based substances produced by iontophoresis.

Nitric oxide donor-mediated killing of bioluminescent Escherichia coli.

Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.

Intranasal monoclonal immunoglobulin A against respiratory syncytial virus protects against upper and lower respiratory tract infections in mice.

Phosphatidylazidothymidine and phosphatidyl-ddC: assessment of uptake in mouse lymphoid tissues and antiviral activities in human immunodeficiency virus-infected cells and in Rauscher leukemia virus-infected mice.

Possible implications of doxycycline-rifampin interaction for treatment of brucellosis.

Mechanism of electrical enhancement of efficacy of antibiotics in killing biofilm bacteria.

Effect of magnesium complexation by fluoroquinolones on their antibacterial properties.

Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children.

Inhibition of cap (m7GpppXm)-dependent endonuclease of influenza virus by 4-substituted 2,4-dioxobutanoic acid compounds.

Extended-spectrum beta-lactamases in clinical isolates of Enterobacter gergoviae and Escherichia coli in China.

Effects of antifungal agent combinations administered simultaneously and sequentially against Aspergillus fumigatus.

Simulation of amoxicillin pharmacokinetics in humans for the prevention of streptococcal endocarditis in rats.

Characterization of the PNT1 pentamidine resistance gene of Saccharomyces cerevisiae.

New in vitro assay based on glucose consumption for determining intraconazole and amphotericin B activities against Aspergillus fumigatus.

New tetrahydroimidazo[4,5,1-jk][1,4]-benzodiazepin-2(1H)-one and -thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs.

Selection and characterization of 5-fluoroorotate-resistant Plasmodium falciparum.

In vitro and in vivo antimycobacterial activities of a new quinolone, DU-6859a.

In vitro and ex vivo effects of cyclosporin A on phagocytic host defenses against Aspergillus fumigatus.

Inhibition of human cytomegalovirus in culture by alkenyl guanine analogs of the thiazolo[4,5-d]pyrimidine ring system.

In vitro activity of SCE-2787, a new cephalosporin with potent activity against Pseudomonas aeruginosa and members of the family Enterobacteriaceae.

In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cefdinir.

Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone.

In vitro activities of 2,2'-bipyridyl analogs against Mycobacterium leprae.

Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds.

Susceptibilities to 10 antimicrobial agents of 1,220 Campylobacter strains isolated from 1987 to 1993 from feces of pediatric patients.

Inhibition of hepatitis B virus in tissue culture by alpha interferon.

Detection of aac(6')-I genes in amikacin-resistant Acinetobacter spp. by PCR.

Human immunodeficiency virus type 1 virions composed of unprocessed Gag and Gag-Pol precursors are capable of reverse transcribing viral genomic RNA.

Year: 1994, Volume: 38, Issue: 11

Year: 1994, Volume: 38, Issue: 10

Year: 1994, Volume: 38, Issue: 9

Year: 1994, Volume: 38, Issue: 8

Year: 1994, Volume: 38, Issue: 7

Year: 1994, Volume: 38, Issue: 6

Year: 1994, Volume: 38, Issue: 5

Year: 1994, Volume: 38, Issue: 4

Year: 1994, Volume: 38, Issue: 3

Year: 1994, Volume: 38, Issue: 2

Year: 1994, Volume: 38, Issue: 1

Year: 1993, Volume: 37

Year: 1992, Volume: 36

Year: 1991, Volume: 35

Year: 1990, Volume: 34

Year: 1989, Volume: 33

Year: 1988, Volume: 32

Year: 1987, Volume: 31

Year: 1986, Volume: 30

Year: 1986, Volume: 29

Year: 1985, Volume: 28

Year: 1985, Volume: 27

Year: 1984, Volume: 26

Year: 1984, Volume: 25

Year: 1983, Volume: 24

Year: 1983, Volume: 23

Year: 1982, Volume: 22

Year: 1982, Volume: 21

Year: 1981, Volume: 20

Year: 1981, Volume: 19

Year: 1980, Volume: 18

Year: 1980, Volume: 17

Year: 1979, Volume: 16

Year: 1979, Volume: 15

Year: 1978, Volume: 14

Year: 1978, Volume: 13

Year: 1977, Volume: 12

Year: 1977, Volume: 11

Year: 1976, Volume: 10

Year: 1976, Volume: 9

Year: 1975, Volume: 8

Year: 1975, Volume: 7

Year: 1974, Volume: 6

Year: 1974, Volume: 5

Year: 1973, Volume: 4

Year: 1973, Volume: 3

Year: 1972, Volume: 2

Year: 1972, Volume: 1

Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients.

Content Provider	PubMed Central
Author	Jehl, F. Muller-serieys, C. Monteil, H. Bergogne-berezin, E. De Larminat, V.
Abstract	The penetration of piperacillin-tazobactam in eight mechanically ventilated intensive care patients (age, 56.0 +/- 12.2 years, and weight, 76.5 +/- 15.2 kg [means +/- standard deviations]) with bacterial pneumonia was investigated. They were given intravenous doses of piperacillin (4 g) and tazobactam (0.5 g) as 30-min infusions every 6 h. The kinetic study was performed after the fourth dose on day 2 of treatment. Samples of blood and bronchial secretions (BS) were collected before the fourth dosing and 0.5, 1, 2, 4, and 6 h after the end of infusion. Drug concentrations in both sera and BS were measured by high-performance liquid chromatography. Concentrations (in micrograms per milliliter) in serum were 184.80 +/- 63.03 and 40.03 +/- 30.79 for piperacillin and 23.05 +/- 7.53 and 4.86 +/- 4.54 for tazobactam at 0.5 and 6 h, respectively, after the end of infusion. The corresponding concentrations (in micrograms per milliliter) in BS were 29.33 +/- 25.08 and 20.25 +/- 19.11 for piperacillin and 6.86 +/- 4.25 and 4.25 +/- 2.78 for tazobactam. The percentages for the extent of penetration of piperacillin and tazobactam, as defined by the BS/serum area under the curve ratio, were 35.70 and 78.42%, respectively. These data indicate good penetration of both piperacillin and tazobactam into BS. The concentrations of tazobactam in BS are persistent and high enough to exceed the values found to be effective in vitro against the tazobactam-susceptible beta-lactamases produced by the most important pathogens responsible for nosocomial pneumonia.
Starting Page	2780
File Format	PDF
ISSN	10986596
e-ISSN	10986596
Journal	Antimicrobial Agents and Chemotherapy
Issue Number	12
Volume Number	38
Language	English
Publisher Date	1994-12-01
Access Restriction	Open
Subject Keyword	Research in Higher Education
Content Type	Text
Resource Type	Article
Subject	Infectious Diseases Pharmacology Pharmacology (medical)

Central Library (ISO-9001:2015 Certified)
Indian Institute of Technology Kharagpur
Kharagpur, West Bengal, India | PIN - 721302

See location in the Map
03222 282435
Mail: support@ndl.gov.in

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in